在報名TIDES Europe時選擇「Post-Event Meeting」作為附加選項，便可以參加會後研討會：「OSI Europe」（11 月 6 日舉行）。
詳情請洽詢 Global Information Co.， Ltd.（環球資訊有限企業）。

Exploring clinical updates from leading GLP-1, dual, and triple agonist programs across peptide and small molecule modalities, including efficacy data and novel oral formulations addressing limitations of injectable therapies.

Exploring RNA-based approaches for obesity, including siRNA-mediated inhibition of metabolic targets and non-coding RNA technologies with insights from Phase 1 clinical data.

Navigating regulatory pathways, reimbursement frameworks, and market access challenges to successfully translate innovative obesity therapeutics into commercially viable solutions across diverse European healthcare systems.

Examining valuation trends, licensing opportunities, and strategic collaborations shaping the obesity therapeutics landscape, with insights from leading investors, pharma BD&L teams, and emerging biotech innovators.

Integrating digital health solutions with obesity therapeutics to enhance patient engagement, treatment adherence, and real-world outcomes through connected technologies and data-driven personalization.

Connect with pharmaceutical executives, biotech innovators, clinical researchers, and investors during structured networking breaks designed to foster collaboration, exchange insights, and build strategic partnerships across the obesity innovation ecosystem.